Intravenous immunoglobulin treatment recovers the down-regulated levels of Th1 cytokines in the sera and skin of scleroderma patients

Journal of Dermatological Science

Volumn 69, Issue 1, 2013, Pages 77-80

  Kudo, Hideo ^a   Jinnin, Masatoshi ^a   Yamane, Keitaro ^a   Makino, Takamitsu ^a   Kajihara, Ikko ^a   Makino, Katsunari ^a   Honda, Noritoshi ^a   Nakayama, Wakana ^a   Fukushima, Satoshi ^a   Ihn, Hironobu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Cytokine; IFN ; IL 12; IVIG; Systemic sclerosis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DOWN REGULATION; ENZYME REPRESSION; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; LETTER; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TISSUE LEVEL; RANDOMIZED CONTROLLED TRIAL; REGULATORY MECHANISM; SKIN BIOPSY; SKIN FIBROSIS; SYSTEMIC SCLEROSIS; TH1 CELL; TISSUE LEVEL; TREATMENT DURATION; TREATMENT OUTCOME; UPREGULATION;

AGED; CYTOKINES; DOUBLE-BLIND METHOD; DOWN-REGULATION; FEMALE; FIBROSIS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; PROTEIN ARRAY ANALYSIS; SCLERODERMA, SYSTEMIC; TH1 CELLS;

EID: 84870946810     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2012.09.010     Document Type: Letter

References (10)

1. Baleva M., Nikolov K. The role of intravenous immunoglobulin preparations in the treatment of systemic sclerosis. Int J Rheumatol 2011, 2011:829751.
2. Asano Y., Ihn H., Asashima N., Yazawa N., Mimura Y., Jinnin M., et al. A case of diffuse scleroderma successfully treated with high-dose intravenous immune globulin infusion. Rheumatology (Oxford) 2005, 44:824-826.
3. Ihn H., Mimura Y., Yazawa N., Jinnin M., Asano Y., Yamane K., et al. High-dose intravenous immunoglobulin infusion as treatment for diffuse scleroderma. Br J Dermatol 2007, 156:1058-1060.
4. Clynes R. IVIG therapy: interfering with interferon-γ. Immunity 2007, 26:4-6.
5. Matsushita T., Hasegawa M., Hamaguchi Y., Takehara K., Sato S. Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis. J Rheumatol 2006, 33:275-284.
6. Grassegger A., Schuler G., Hessenberger G., Walder-Hantich B., Jabkowski J., MacHeiner W., et al. Interferon-γ in the treatment of systemic sclerosis: a randomized controlled multicentre trial. Br J Dermatol 1998, 139:639-648.
7. Amemiya K., Semino-Mora C., Granger R.P., Dalakas M.C. Downregulation of TGF-β1 mRNA and protein in the muscles of patients with inflammatory myopathies after treatment with high-dose intravenous immunoglobulin. Clin Immunol 2000, 94:99-104.
8. Sato S., Hanakawa H., Hasegawa M., Nagaoka T., Hamaguchi Y., Nishijima C., et al. Levels of interleukin 12, a cytokine of type 1 helper T cells, are elevated in sera from patients with systemic sclerosis. J Rheumatol 2000, 27:2838-2842.
9. Muscat C., Bertotto A., Ercolani R., Bistoni O., Agea E., Cesarotti M., et al. Long term treatment of rheumatoid arthritis with high doses of intravenous immunoglobulins: effects on disease activity and serum cytokines. Ann Rheum Dis 1995, 54:382-385.
10. Jee S.J., Kim J.H., Baek H.S., Lee H.B., Oh J.W. Long-term efficacy of intravenous immunoglobulin therapy for moderate to severe childhood atopic dermatitis. Allergy Asthma Immunol Res 2011, 3:89-95.